Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection

By R. Salvia, C. Castillo, C. Bassi, S. Thayer, M. Falconi, W. Mantovani, P. Pederzoli, A. Warshaw. Annals of Surgery, 2004

777 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (2017, methodology): “2), with a recommendation of evaluation but no immediate resection [6,7,9], although one study reported a high rate of “ malignant ” IPMN (59”
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011, background): “Although some of the difference in survival is due to differences in stage at diagnosis, investigators have suggested that “carcinoma arising in IPMNs is a different disease” from the more common type of PDA that develops without any associated cystic precursor (15).”